Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Sequential Bilateral Accelerated Theta Burst Stimulation in Adolescents With Suicidal Ideation

NCT: NCT04502758 · COMPLETED

NCT IDNCT04502758
StatusCOMPLETED
Start Date2022-04-04
Completion2026-06-30
SponsorMayo Clinic (OTHER)
First posted
Last updated

Brief Summary

The purpose of this study is to gather information regarding the use of a new type of transcranial magnetic stimulation (TMS) called theta burst stimulation (TBS) for suicidal ideation in adolescents with Major Depressive Disorder (MDD). The investigators hope to learn if this TMS treatment improves suicidal ideation over 10 days and clinical outcomes over 1 year of follow-up.

Frequently Asked Questions

What is Sequential Bilateral Accelerated Theta Burst Stimulation in Adolescents With Suicidal Ideation?

Sequential Bilateral Accelerated Theta Burst Stimulation in Adolescents With Suicidal Ideation is a clinical trial registered under NCT04502758. Current status: COMPLETED.

What is the status of NCT04502758?

The current status of NCT04502758 (Sequential Bilateral Accelerated Theta Burst Stimulation in Adolescents With Suicidal Ideation) is: COMPLETED.

When did Sequential Bilateral Accelerated Theta Burst Stimulation in Adolescents With Suicidal Ideation start?

Sequential Bilateral Accelerated Theta Burst Stimulation in Adolescents With Suicidal Ideation started on 2022-04-04.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.